Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19

BACKGROUND: Limited data are available regarding hydroxychloroquine (HCQ) and moxifloxacin (MOX) in patients with possible coronavirus disease 2019, (COVID-19). Both drugs may increase risk of malignant ventricular arrhythmias associated with prolongation of QT interval. METHODS: A total of 76 subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Afsin, Abdulmecit, Ecemis, Kenan, Asoglu, Ramazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430923/
https://www.ncbi.nlm.nih.gov/pubmed/32849949
http://dx.doi.org/10.14740/jocmr4288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430923/
https://www.ncbi.nlm.nih.gov/pubmed/32849949
http://dx.doi.org/10.14740/jocmr4288

Ejemplares similares